Keros Therapeutics (KROS) Operating Margin Growth (1y) (2024 - 2025)

Keros Therapeutics (KROS) Operating Margin Growth (1y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 3,609.00
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 1,536.00
9 Abivax 94.37 Bn 94.37 Bn - -
10 Keros Therapeutics 372.58 Mn 85.18 Mn - -1.56 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.56 Mn
Sep 30, 2025 1.50 Mn
Dec 31, 2024 4.30 Mn
Sep 30, 2024 52.59 Mn